Alkabban FM, Ferguson T. Cancer, breast. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing 2020.
van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, Poortmans P, Strobbe LJA, Siesling S. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–70.
Christiansen P, Carstensen SL, Ejlertsen B, Kroman N, Offersen B, Bodilsen A, Jensen MB. Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 2018;57(1):19–25.
Gentilini OD, Cardoso MJ, Poortmans P. Less is more. Breast conservation might be even better than mastectomy in early breast cancer patients. Breast. 2017;35:32–3.
Chen QX, Wang XX, Lin PY, Zhang J, Li JJ, Song CG, Shao ZM. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database. Oncotarget. 2017;8(3):4773–80.
Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA. 2014;312(9):902–14.
Article CAS PubMed PubMed Central Google Scholar
Lagendijk M, van Maaren MC, Saadatmand S, Strobbe LJA, Poortmans PMP, Koppert LB, Tilanus-Linthorst MMA, Siesling S. Breast conserving therapy and mastectomy revisited: breast cancer-specific survival and the influence of prognostic factors in 129,692 patients. Int J Cancer. 2018;142(1):165–75.
Article CAS PubMed Google Scholar
Peart O. Breast intervention and breast cancer treatment options. Radiol Technol. 2015;86(5):535 M–58.
Ten Wolde B, Kuiper M, de Wilt JHW, Strobbe LJA. Postoperative complications after breast Cancer surgery are not related to age. Ann Surg Oncol. 2017;24(7):1861–7.
de Boniface J, Szulkin R, Johansson ALV. Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women. Br J Surg. 2023;110(3):344–52.
Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–5.
Article CAS PubMed Google Scholar
Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005;17(4):359–65.
Article CAS PubMed Google Scholar
Hirsiger S, Simmen HP, Werner CM, Wanner GA, Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm. 2012;2012:315941.
Article PubMed PubMed Central Google Scholar
Benarroch EE. Autonomic-mediated immunomodulation and potential clinical relevance. Neurology. 2009;73(3):236–42.
Pinho-Ribeiro FA, Verri WA Jr., Chiu IM. Nociceptor sensory Neuron-Immune interactions in Pain and inflammation. Trends Immunol. 2017;38(1):5–19.
Article CAS PubMed Google Scholar
Meijer F, Honing M, Roor T, Toet S, Calis P, Olofsen E, Martini C, van Velzen M, Aarts L, Niesters M, et al. Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial. Br J Anaesth. 2020;125(6):1070–8.
Article CAS PubMed PubMed Central Google Scholar
Fragiadakis GK, Gaudillière B, Ganio EA, Aghaeepour N, Tingle M, Nolan GP, Angst MS. Patient-specific Immune States before surgery are strong correlates of Surgical Recovery. Anesthesiology. 2015;123(6):1241–55.
Article CAS PubMed Google Scholar
Hazeldine J, Naumann DN, Toman E, Davies D, Bishop JRB, Su Z, Hampson P, Dinsdale RJ, Crombie N, Duggal NA, et al. Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort study. PLoS Med. 2017;14(7):e1002338.
Article PubMed PubMed Central Google Scholar
Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van Laarhoven A, van der Hoeven H, Scheffer GJ, Pickkers P. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016;42(4):551–61.
Article CAS PubMed PubMed Central Google Scholar
Mittempergher L, Saghatchian M, Wolf DM, Michiels S, Canisius S, Dessen P, Delaloge S, Lazar V, Benz SC, Tursz T, et al. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences. Mol Oncol. 2013;7(5):987–99.
Article CAS PubMed PubMed Central Google Scholar
Leijte GP, Custers H, Gerretsen J, Heijne A, Roth J, Vogl T, Scheffer GJ, Pickkers P, Kox M. Increased plasma levels of Danger-Associated molecular patterns are Associated with Immune suppression and postoperative infections in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Front Immunol. 2018;9:663.
Article PubMed PubMed Central Google Scholar
Gunaldi M, Okuturlar Y, Gedikbasi A, Akarsu C, Karabulut M, Kural A. Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomed Pharmacother. 2015;76:52–6.
Article CAS PubMed Google Scholar
Jiang Y, Chen L, Shen J, Mei X, Yao J, Chen T, Zhou Y. The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer. Aging. 2021;13(17):20886–95.
Article CAS PubMed PubMed Central Google Scholar
Hsieh HL, Schäfer BW, Sasaki N, Heizmann CW. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun. 2003;307(2):375–81.
Article CAS PubMed Google Scholar
Máca J, Burša F, Ševčík P, Sklienka P, Burda M, Holub M. Alarmins and clinical outcomes after major abdominal Surgery-A prospective study. J Invest Surg. 2017;30(3):152–61.
Åberg AM, Bergström SH, Thysell E, Tjon-Kon-Fat LA, Nilsson JA, Widmark A, Thellenberg-Karlsson C, Bergh A, Wikström P, Lundholm M. High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer. Cancers (Basel) 2021, 13(10).
Lu C, Liu J, Yao M, Li L, Li G. Downregulation of S100 calcium binding protein A12 inhibits the growth of glioma cells. BMC Cancer. 2020;20(1):261.
Article CAS PubMed PubMed Central Google Scholar
Wang X, Sun Z, Tian W, Piao C, Xie X, Zang J, Peng S, Yu X, Wang Y. S100A12 is a promising biomarker in papillary thyroid cancer. Sci Rep. 2020;10(1):1724.
Article CAS PubMed PubMed Central Google Scholar
Khorramdelazad H, Bagheri V, Hassanshahi G, Karami H, Moogooei M, Zeinali M, Abedinzadeh M. S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression? Asian Pac J Cancer Prev. 2015;16(7):2725–9.
Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165–78.
Article CAS PubMed PubMed Central Google Scholar
Kox M, Vrouwenvelder MQ, Pompe JC, van der Hoeven JG, Pickkers P, Hoedemaekers CW. The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma. 2012;29(5):747–55.
Ben-Israel N, Kliger M, Zuckerman G, Katz Y, Edry R. Monitoring the nociception level: a multi-parameter approach. J Clin Monit Comput. 2013;27(6):659–68.
Meijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: a Randomized Controlled Trial. Anesthesiology. 2019;130(5):745–55.
Article CAS PubMed Google Scholar
Morisson L, Nadeau-Vallée M, Espitalier F, Laferrière-Langlois P, Idrissi M, Lahrichi N, Gélinas C, Verdonck O, Richebé P. Prediction of acute postoperative pain based on intraoperative nociception level (NOL) index values: the impact of machine learning-based analysis. J Clin Monit Comput. 2023;37(1):337–44.
Goradia S, Sardaneh AA, Narayan SW, Penm J, Patanwala AE. Vasopressor dose equivalence: a scoping review and suggested formula. J Crit Care. 2021;61:233–40.
Article CAS PubMed Google Scholar
Nowak P, Nystrom J, Troseid M. High levels of HMGB1 in plasma may be due to ex vivo cell necrosis. Anticancer Res. 2012;32(9):4067–9.
Madách K, Molvarec A, Rigó J Jr., Nagy B, Pénzes I, Karádi I, Prohászka Z. Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):133–8.
留言 (0)